Review

Advances in the role of circular RNA in schizophrenia

  • Lirong FU ,
  • Chen ZHANG
Expand
  • Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
ZHANG Chen, E-mail: zhangchen645@gmail.com.

Received date: 2023-05-10

  Accepted date: 2023-10-27

  Online published: 2023-11-28

Supported by

Natural Science Foundation of China(82271538);Shanghai Youth Science and Technology Stars and Outstanding Discipline Leaders Program(20XD1403100);Western Medicine Guide Project of Science and Technology Commission of Shanghai Municipality(19411969300)

Abstract

Schizophrenia is a complex and severe mental disorder, the precise cause of which remains unknown. Circular RNA (circRNA), a type of non-coding RNA with a loop-like structure, is abundant in eukaryotic cell transcriptomes. Recent advancements in molecular genetics have allowed researchers to gain a better understanding of circRNA′s expression profile and biological functions. These molecules play critical roles in various biological processes, including regulation of gene expression, synaptic plasticity, and cognitive flexibility. Due to its high concentration in the mammalian brain, circRNA is involved in neurodevelopment and the maintenance of neural function. Changes in circRNA levels, both within and outside of cells, have been linked to numerous neuro-psychiatric disorders, including schizophrenia. As such, circRNA has a crucial and distinctive function in neuro-psychiatric disorders. Given its characteristics, biological functions, and regulatory roles in diseases, researchers are exploring the abnormal expression of circRNA in schizophrenia and its connection to the onset and progression of the disease. Among them, exosomal circRNA, due to its high stability, disease specificity, and abundant content, is poised to become a potential biological marker for diagnosing schizophrenia. This article provides an extensive overview of the recent circRNA and schizophrenia research, discussing the possibility of using exosomal circRNA as a diagnostic biomarker and therapeutic target for schizophrenia.

Cite this article

Lirong FU , Chen ZHANG . Advances in the role of circular RNA in schizophrenia[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(11) : 1445 -1449 . DOI: 10.3969/j.issn.1674-8115.2023.11.013

References

1 MAHMOUDI E, GREEN M J, CAIRNS M J. Dysregulation of circRNA expression in the peripheral blood of individuals with schizophrenia and bipolar disorder[J]. J Mol Med (Berl), 2021, 99(7): 981-991.
2 ENUKA Y, LAURIOLA M, FELDMAN M E, et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor[J]. Nucleic Acids Res, 2016, 44(3): 1370-1383.
3 NEDOLUZHKO A, GRUZDEVA N, SHARKO F, et al. The biomarker and therapeutic potential of circular RNAs in schizophrenia[J]. Cells, 2020, 9(10): 2238.
4 HUANG A Q, ZHENG H X, WU Z Y, et al. Circular RNA-protein interactions: functions, mechanisms, and identification[J]. Theranostics, 2020, 10(8): 3503-3517.
5 ZAIOU M. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases[J]. Adv Exp Med Biol, 2019, 1134: 177-191.
6 HOLDT L M, KOHLMAIER A, TEUPSER D. Molecular roles and function of circular RNAs in eukaryotic cells[J]. Cell Mol Life Sci, 2018, 75(6): 1071-1098.
7 LEGNINI I, DI TIMOTEO G, ROSSI F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis[J]. Mol Cell, 2017, 66(1): 22-37.e9.
8 ZENG X X, LIN W, GUO M Z, et al. A comprehensive overview and evaluation of circular RNA detection tools[J]. PLoS Comput Biol, 2017, 13(6): e1005420.
9 ZHUO C J, HOU W H, JIANG D G, et al. Circular RNAs in early brain development and their influence and clinical significance in neuropsychiatric disorders[J]. Neural Regen Res, 2020, 15(5): 817-823.
10 LI Z X, LIU S, LI X R, et al. Circular RNA in schizophrenia and depression[J]. Front Psychiatry, 2020, 11: 392.
11 CUI X L, NIU W, KONG L M, et al. hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in major depressive disorder[J]. Biomark Med, 2016, 10(9): 943-952.
12 ZHANG Y, DU L F, BAI Y, et al. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination[J]. Mol Psychiatry, 2020, 25(6): 1175-1190.
13 CHEN W, QIN C. General hallmarks of microRNAs in brain evolution and development[J]. RNA Biol, 2015, 12(7): 701-708.
14 HANSEN T B, JENSEN T I, CLAUSEN B H, et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013, 495(7441): 384-388.
15 LASDA E, PARKER R. Circular RNAs: diversity of form and function[J]. RNA, 2014, 20(12): 1829-1842.
16 HANNA J, HOSSAIN G S, KOCERHA J. The potential for microRNA therapeutics and clinical research[J]. Front Genet, 2019, 10: 478.
17 MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature, 2013, 495(7441): 333-338.
18 YU C Y, KUO H C. The emerging roles and functions of circular RNAs and their generation[J]. J Biomed Sci, 2019, 26(1): 29.
19 MAHMOUDI E, FITZSIMMONS C, GEAGHAN M P, et al. Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNA[J]. Neuropsychopharmacology, 2019, 44(6): 1043-1054.
20 PIWECKA M, GLA?AR P, HERNANDEZ-MIRANDA L R, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function[J]. Science, 2017, 357(6357): eaam8526.
21 ZIMMERMAN A J, HAFEZ A K, AMOAH S K, et al. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition[J]. Mol Psychiatry, 2020, 25(11): 2712-2727.
22 YELICK J, MEN Y Q, JIN S J, et al. Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS[J]. Exp Neurol, 2020, 333: 113414.
23 LIAO F P, ZHU L L, YANG J L, et al. Whole transcriptome sequencing identified circRNA profiles and the related networks in schizophrenia[J]. J Mol Neurosci, 2022, 72(8): 1622-1635.
24 YAO G F, NIU W, ZHU X L, et al. hsa_circRNA_104597: a novel potential diagnostic and therapeutic biomarker for schizophrenia[J]. Biomark Med, 2019, 13(5): 331-340.
25 YAMAMOTO T, KOSAKA N, OCHIYA T. Latest advances in extracellular vesicles: from bench to bedside[J]. Sci Technol Adv Mater, 2019, 20(1): 746-757.
26 RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. J Cell Biol, 2013, 200(4): 373-383.
27 SHAH R, PATEL T, FREEDMAN J E. Circulating extracellular vesicles in human disease[J]. N Engl J Med, 2018, 379(10): 958-966.
28 ZHANG G, YANG P. A novel cell-cell communication mechanism in the nervous system: exosomes[J]. J Neurosci Res, 2018, 96(1): 45-52.
29 LI Y C, ZHAO J J, YU S L, et al. Extracellular vesicles long RNA sequencing reveals abundant mRNA, circRNA, and lncRNA in human blood as potential biomarkers for cancer diagnosis[J]. Clin Chem, 2019, 65(6): 798-808.
30 LI Y, ZHENG Q P, BAO C Y, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis[J]. Cell Res, 2015, 25(8): 981-984.
31 DU Y, TAN W L, CHEN L, et al. Exosome transplantation from patients with schizophrenia causes schizophrenia-relevant behaviors in mice: an integrative multi-omics data analysis[J]. Schizophr Bull, 2021, 47(5): 1288-1299.
32 TAN G F, WANG L M, LIU Y Y, et al. The alterations of circular RNA expression in plasma exosomes from patients with schizophrenia[J]. J Cell Physiol, 2021, 236(1): 458-467.
33 GUO C, LV H B, BAI Y L, et al. Circular RNAs in extracellular vesicles: promising candidate biomarkers for schizophrenia[J]. Front Genet, 2023, 13: 997322.
34 SINGH M, DWIBEDY S L L, BISWAL S R, et al. Circular RNA: a novel and potential regulator in pathophysiology of schizophrenia[J]. Metab Brain Dis, 2022, 37(5): 1309-1316.
35 SHARMA A R, BHATTACHARYA M, BHAKTA S, et al. Recent research progress on circular RNAs: biogenesis, properties, functions, and therapeutic potential[J]. Mol Ther Nucleic Acids, 2021, 25: 355-371.
Outlines

/